Clinical Trial Update: Daratumumab/Daratumumab and Hyaluronidase-fihj in Combination With Pomalidomide and Dexamethasone for the Treatment of Patients With Newly Diagnosed AL Amyloidosis: a Prospective, Multicenter, Single-arm Study [NA]

View source ↗

Summary

This clinical trial investigates a regimen of daratumumab with hyaluronidase-fihj, pomalidomide, and dexamethasone for newly diagnosed AL (amyloid light-chain) …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyloid Light-chain Amyloidosis

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Daratumumab (daratumumab)
• Hyaluronidase-fihj (hyaluronidase-fihj)
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: Yongyong MA | Conditions: Amyloid Light-chain Amyloidosis | NA | Status: RECRUITING